Robert W. Ashworth
General Counsel bei ATYR PHARMA, INC.
Aktive Positionen von Robert W. Ashworth
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ATYR PHARMA, INC. | General Counsel | 06.10.2021 | - |
Karriereverlauf von Robert W. Ashworth
Ehemalige bekannte Positionen von Robert W. Ashworth
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ONCOSEC MEDICAL INCORPORATED | General Counsel | 30.07.2018 | - |
| Corporate Officer/Principal | - | 01.09.2021 | |
| AYALA PHARMACEUTICALS, INC. | Compliance Officer | 01.01.2015 | 01.01.2018 |
| General Counsel | 01.01.2015 | 01.01.2018 | |
Otsuka Pharmaceutical Development & Commercialization, Inc.
 Otsuka Pharmaceutical Development & Commercialization, Inc. Pharmaceuticals: MajorHealth Technology Part of Otsuka Holdings Co., Ltd., Otsuka Pharmaceutical Development & Commercialization, Inc. is a healthcare company that was founded in 2007. The company is based in Princeton, NJ. The company is driven by their purpose and defined by their beliefs. | General Counsel | - | - |
| NPS PHARMACEUTICALS, INC. | General Counsel | - | - |
Ausbildung von Robert W. Ashworth
| Massachusetts Institute of Technology | Doctorate Degree |
| St. John's University | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 8 |
Operativ
| General Counsel | 5 |
| Compliance Officer | 1 |
| Doctorate Degree | 1 |
Sektoral
| Health Technology | 5 |
| Finance | 2 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ONCOSEC MEDICAL INCORPORATED | Health Services |
| ATYR PHARMA, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Advaxis, Inc.
 Advaxis, Inc. Pharmaceuticals: MajorHealth Technology Advaxis, Inc. is a biotechnology company, which engages in the discovery, development and commercialization of cancer immunotherapies. It manages platform technology that utilizes live attenuated Listeria monocytogenes bioengineered to secrete antigen or adjuvant fusion proteins. The firm has four franchises in various stages of clinical and pre-clinical development, namely: HPV-associated cancers, prostate cancer, neoantigen therapy and hotspot mutation therapy. The company was founded on June 5, 1987 and is headquartered in Princeton, NJ. | Health Technology |
NPS Pharmaceuticals, Inc.
 NPS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NPS Pharmaceuticals, Inc. developed drugs for bone and mineral disorders. It also developed Natpara for the treatment of adult hypoparathyroidism. The company was founded by Hunter Jackson and Thomas N. Parks on October 22, 1986 and is headquartered in Bedminster, NJ. | Health Technology |
Otsuka Pharmaceutical Development & Commercialization, Inc.
Otsuka Pharmaceutical Development & Commercialization, Inc. Pharmaceuticals: MajorHealth Technology Part of Otsuka Holdings Co., Ltd., Otsuka Pharmaceutical Development & Commercialization, Inc. is a healthcare company that was founded in 2007. The company is based in Princeton, NJ. The company is driven by their purpose and defined by their beliefs. | Health Technology |
- Börse
- Insiders
- Robert W. Ashworth
- Erfahrung